Spark Investment Management LLC Cyma Bay Therapeutics, Inc. Transaction History

Spark Investment Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 12, 2020	SELL	$1.41 - $4.25 $73,308 - $220,966	-51,992 Closed	0 $0
Q1 2020 May 12, 2020	SELL	$1.25 - $2.02 $272,531 - $440,410	-218,025 Reduced 80.74%	51,992 $76,000
Q3 2019 Nov 12, 2019	BUY	$5.12 - $7.21 $142,423 - $200,560	27,817 Added 11.49%	270,017 $1.38 Million
Q2 2019 Aug 12, 2019	BUY	$6.05 - $13.66 $353,320 - $797,744	58,400 Added 31.77%	242,200 $1.73 Million
Q1 2019 May 07, 2019	BUY	$8.16 - $13.42 $485,520 - $798,490	59,500 Added 47.87%	183,800 $2.44 Million
Q4 2018 Feb 12, 2019	BUY	$6.54 - $11.74 $812,922 - $1.46 Million	124,300 New	124,300 $978,000

1.82M

Ticker CBAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,677,904
Description
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...

Get notified when there are updates to the investment portfolio of Spark Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Spark Investment Management LLC with notifications on news.